Literature DB >> 21248087

Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan.

Seiichiro Fujisaki1, Yoshiyuki Yokomaku, Teiichiro Shiino, Tomohiko Koibuchi, Junko Hattori, Shiro Ibe, Yasumasa Iwatani, Aikichi Iwamoto, Takuma Shirasaka, Motohiro Hamaguchi, Wataru Sugiura.   

Abstract

The major routes of hepatitis B virus (HBV) infection in Japan has been mother-to-child transmission (MTCT) and blood transfusion. However, HBV cases transmitted through sexual contact are increasing, especially among HIV-1-seropositive patients. To understand the molecular epidemiology of HBV in HBV/HIV-1 coinfection, we analyzed HBV genotypes and HIV-1 subtypes in HBV/HIV-1-coinfected patients at Nagoya Medical Center from 2003 to 2007. Among 394 HIV-1-infected Japanese men having sex with men (MSM) who were newly diagnosed during the study period, 31 (7.9%) tested positive for the hepatitis B virus surface antigen. HBV sequence analyses were successful in 26 cases, with 21 (80.7%) and 5 (19.3%) cases determined as genotypes A and C, respectively. Our finding that HBV genotype A was dominant in HIV-1-seropositive patients alerts clinicians to an alternative outbreak of HBV genotype A in the HIV-1-infected MSM population and a shift in HBV genotype from C to A in Japan. The narrow genetic diversity in genotype A cases suggests that genotype A has been recently introduced into the MSM population and that sexual contacts among MSM were more active than speculated from HIV-1 tree analyses. In addition, we found a lamivudine resistance mutation in one naïve case, suggesting a risk of drug-resistant HBV transmission. As genotype A infection has a higher risk than infection with other genotypes for individuals to become HBV carriers, prevention programs are urgently needed for the target population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248087      PMCID: PMC3067677          DOI: 10.1128/JCM.02149-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Further decline of hepatitis B surface antigen (HBsAg) prevalence in Japan.

Authors:  T Oda
Journal:  Jpn J Cancer Res       Date:  2000-03

2.  Predominance of genotype A HBV in an HBV-HIV-1 dually positive population compared with an HIV-1-negative counterpart in Japan.

Authors:  T Koibuchi; A Hitani; T Nakamura; N Nojiri; K Nakajima; T Jyuji; A Iwamoto
Journal:  J Med Virol       Date:  2001-08       Impact factor: 2.327

3.  A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness.

Authors:  Fuminaka Sugauchi; Masashi Mizokami; Etsuro Orito; Tomoyoshi Ohno; Hideaki Kato; Seiji Suzuki; Yoshihide Kimura; Ryuzo Ueda; L A Butterworth; W G E Cooksley
Journal:  J Gen Virol       Date:  2001-04       Impact factor: 3.891

4.  Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan.

Authors:  E Orito; T Ichida; H Sakugawa; M Sata; N Horiike; K Hino; K Okita; T Okanoue; S Iino; E Tanaka; K Suzuki; H Watanabe; S Hige; M Mizokami
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

5.  Perinatal transmission of hepatitis B virus and its prevention.

Authors:  K Shiraki
Journal:  J Gastroenterol Hepatol       Date:  2000-05       Impact factor: 4.029

6.  The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach.

Authors:  O G Pybus; A J Drummond; T Nakano; B H Robertson; A Rambaut
Journal:  Mol Biol Evol       Date:  2003-03       Impact factor: 16.240

7.  Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe.

Authors:  Vincent Soriano; Amanda Mocroft; Lars Peters; Juergen Rockstroh; Francisco Antunes; Nikolai Kirkby; Stephane de Wit; Antonella d'Arminio Monforte; Robert Flisiak; Jens Lundgren
Journal:  J Antimicrob Chemother       Date:  2010-01-05       Impact factor: 5.790

8.  Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks.

Authors:  Huiling Yang; Christopher E Westland; William E Delaney; Elizabeth J Heathcote; Victoria Ho; John Fry; Carol Brosgart; Craig S Gibbs; Michael D Miller; Shelly Xiong
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

9.  Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980-1994.

Authors:  Hiroshi Noto; Toshihiko Terao; Shigeo Ryou; Yasuyuki Hirose; Takami Yoshida; Hideo Ookubo; Hidetoshi Mito; Hiroshi Yoshizawa
Journal:  J Gastroenterol Hepatol       Date:  2003-08       Impact factor: 4.029

10.  Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B.

Authors:  Christopher E Westland; Huiling Yang; William E Delaney; Craig S Gibbs; Michael D Miller; Michael Wulfsohn; John Fry; Carol L Brosgart; Shelly Xiong
Journal:  Hepatology       Date:  2003-07       Impact factor: 17.425

View more
  18 in total

Review 1.  Is there any value to hepatitis B virus genotype analysis?

Authors:  Sudeep Tanwar; Geoffrey Dusheiko
Journal:  Curr Gastroenterol Rep       Date:  2012-02

2.  Recent population expansions of hepatitis B virus in the United States.

Authors:  Sumathi Ramachandran; Michael A Purdy; Guo-liang Xia; David S Campo; Zoya E Dimitrova; Eyasu H Teshale; Chong Gee Teo; Yury E Khudyakov
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

3.  Hepatitis B virus reactivation associated with temozolomide for malignant glioma: a case report and recommendation for prophylaxis.

Authors:  Yasunori Fujimoto; Naoya Hashimoto; Manabu Kinoshita; Yuko Miyazaki; Satoshi Tanaka; Takayuki Yakushijin; Tetsuo Takehara; Naoki Kagawa; Toshiki Yoshimine
Journal:  Int J Clin Oncol       Date:  2011-08-03       Impact factor: 3.402

Review 4.  Viral hepatitis and human immunodeficiency virus co-infections in Asia.

Authors:  Takako Utsumi; Maria I Lusida
Journal:  World J Virol       Date:  2015-05-12

Review 5.  Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter?

Authors:  Gianguglielmo Zehender; Erika Ebranati; Elena Gabanelli; Chiara Sorrentino; Alessandra Lo Presti; Elisabetta Tanzi; Massimo Ciccozzi; Massimo Galli
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

6.  Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B.

Authors:  Tatsuo Kanda; Masami Shinozaki; Hidehiro Kamezaki; Shuang Wu; Shingo Nakamoto; Makoto Arai; Keiichi Fujiwara; Nobuaki Goto; Fumio Imazeki; Osamu Yokosuka
Journal:  Int J Med Sci       Date:  2011-11-10       Impact factor: 3.738

Review 7.  Prevalence of Hepatitis B Co-Infection among HIV Positive Patients: Narrative Review Article.

Authors:  Azam Askari; Hamid Hakimi; Behzad Nasiri Ahmadabadi; Gholamhossein Hassanshahi; Mohammad Kazemi Arababadi
Journal:  Iran J Public Health       Date:  2014-06       Impact factor: 1.429

8.  Prevalence and epidemiological traits of HIV infections in populations with high-risk behaviours as revealed by genetic analysis of HBV.

Authors:  Y Kojima; T Kawahata; H Mori; K Furubayashi; Y Taniguchi; A Iwasa; K Taniguchi; H Kimura; J Komano
Journal:  Epidemiol Infect       Date:  2013-01-25       Impact factor: 4.434

9.  Prevalence of Anal Human Papillomavirus Infection and Risk Factors among HIV-positive Patients in Tokyo, Japan.

Authors:  Naoyoshi Nagata; Kazuhiro Watanabe; Takeshi Nishijima; Kenichi Tadokoro; Koji Watanabe; Takuro Shimbo; Ryota Niikura; Katsunori Sekine; Junichi Akiyama; Katsuji Teruya; Hiroyuki Gatanaga; Yoshimi Kikuchi; Naomi Uemura; Shinichi Oka
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

10.  Phylogenetic Analysis of Hepatitis B Virus Genotypes Circulating in Different Risk Groups of Panama, Evidence of the Introduction of Genotype A2 in the Country.

Authors:  Alexander A Martínez; Yamitzel Zaldívar; Griselda Arteaga; Zoila de Castillo; Alma Ortiz; Yaxelis Mendoza; Omar Castillero; Juan A Castillo; Juan Cristina; Juan M Pascale
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.